Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
Share Facebook Twitter LinkedIn Pinterest Email Preston Stone connected with Griffin Wilde on a 12-yard touchdown pass, extending the Northwestern Wildcats’ lead over the Purdue Boilermakers.
